{
  "actions": [
    {
      "acted_at": "2013-01-23", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2013-01-23", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to House Energy and Commerce", 
      "type": "referral"
    }, 
    {
      "acted_at": "2013-01-23", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "text": "Referred to House Ways and Means", 
      "type": "referral"
    }, 
    {
      "acted_at": "2013-01-25", 
      "in_committee": null, 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2013-02-08", 
      "in_committee": null, 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr413-113", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }, 
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "02"
    }
  ], 
  "congress": "113", 
  "cosponsors": [
    {
      "district": "1", 
      "name": "Braley, Bruce L.", 
      "sponsored_at": "2013-01-23", 
      "state": "IA", 
      "thomas_id": "01845", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "5", 
      "name": "Cooper, Jim", 
      "sponsored_at": "2013-01-23", 
      "state": "TN", 
      "thomas_id": "00231", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "22", 
      "name": "Hanna, Richard L.", 
      "sponsored_at": "2013-01-23", 
      "state": "NY", 
      "thomas_id": "02044", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2013-01-23", 
  "number": "413", 
  "official_title": "To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": null, 
  "sponsor": {
    "district": null, 
    "name": "Welch, Peter", 
    "state": "VT", 
    "thomas_id": "01879", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2013-01-23", 
  "subjects": [
    "Digestive and metabolic diseases", 
    "Drug and radiation therapy", 
    "Health", 
    "Health care coverage and access", 
    "Medicaid", 
    "Prescription drugs"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2013-01-23", 
    "text": "Amends the American Taxpayer Relief Act of 2012 to eliminate the two-year delay (until January 1, 2016) of the authority of the Secretary of Health and Human Services (HHS) to implement oral-only End Stage Renal Disease (ESRD)-related drugs in the ESRD prospective payment system (PPS) under title XVIII (Medicare) of the Social Security Act. (Thus authorizes the Secretary to implement such drugs in the ESRD-PPS immediately.)"
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-11-03T11:07:28-05:00"
}